Skip to main content
. 2014 Jun 18;5(14):5428–5438. doi: 10.18632/oncotarget.2117

Fig. 2. Resistance to cetuximab was associated with AurkA/STK15 Phe31Ile polymorphism (UD3, UD4, and HN).

Fig. 2

The cell lines UD5, UD7, and Cal27, which are homozygous wildtype for Phe31, exhibited a significant decrease in clonogenic survival.